OSLO, Norway--(BUSINESS WIRE)--OncoImmunity has become the first company to obtain a CE-IVD mark for the clinical use of a machine-learning based neoantigen prediction technology. This quality ...

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence Markets in IVD" report has been added to ResearchAndMarkets.com's offering. This report examines selected AI-based initiatives, collaborations ...